首页> 美国卫生研究院文献>American Journal of Physiology - Regulatory Integrative and Comparative Physiology >Altered expression of hepatic β-adrenergic receptors in aging rats: implications for age-related metabolic dysfunction in liver
【2h】

Altered expression of hepatic β-adrenergic receptors in aging rats: implications for age-related metabolic dysfunction in liver

机译:衰老大鼠肝β-肾上腺素能受体的表达变化:对肝脏年龄相关代谢功能障碍的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Increased β-adrenergic receptor (β-AR)-mediated activation of adenylyl cyclase (AC) in rat liver during aging has been linked to age-related increases in hepatic glucose output and hepatosteatosis. In this study, we investigated the expression of β-ARs, individual receptor subtypes, and G protein-coupled receptor (GPCR) regulatory proteins in livers from aging rats. Radioligand-binding studies demonstrated that β-AR density increased by greater than threefold in hepatocyte membranes from senescent (24-mo-old) compared with young adult (7-mo-old) rats and that this phenomenon was blocked by food restriction, which is known to retard aging processes in rodents. Competition-binding studies revealed a mixed population of β1- and β2-AR subtypes in liver membranes over the adult life span, with a trend for greater β2-AR density with age. Expression of both β-AR subtype mRNAs in rat liver increased with age, whereas β2- but not β1-AR protein levels declined in livers of old animals. Immunoreactive β2- but not β1-ARs were preferentially distributed in pericentral hepatic regions. Levels of GRK2/3 and β-arrestin 2 proteins, which are involved in downregulation of agonist-activated GPCRs, including β-ARs, increased during aging. Insofar as sympathetic tone increases with age, our findings suggest that, despite enhanced agonist-mediated downregulation of hepatic β-ARs preferentially affecting the β2-AR subtype, increased generation of both receptor subtypes during aging augments the pool of plasma membrane-bound β-ARs coupled to AC in hepatocytes. This study thus identifies one or both β-AR subtypes as possible therapeutic targets involved in aberrant hepatic processes of glucose and lipid metabolism during aging.
机译:在衰老过程中,大鼠肝脏中β-肾上腺素能受体(β-AR)介导的腺苷酸环化酶(AC)活化增加与肝脏葡萄糖输出量增加和肝脂肪变性相关。在这项研究中,我们调查了衰老大鼠肝脏中β-ARs,单个受体亚型和G蛋白偶联受体(GPCR)调节蛋白的表达。放射性配体结合研究表明,与成年(7月龄)成年大鼠相比,衰老(24月龄)的肝细胞膜中β-AR密度增加了三倍以上,并且这种现象被食物限制所阻止。已知它可以延缓啮齿动物的衰老过程。竞争结合研究表明,在成年后的整个生命周期中,肝细胞膜中存在β1-AR和β2-AR亚型的混合种群,并且随着年龄的增长,β2-AR密度呈增加趋势。大鼠肝脏中两种β-AR亚型mRNA的表达均随年龄增加而增加,而老年动物肝脏中β2-AR蛋白水平却没有下降。免疫反应性β2-而非β1-ARs优先分布在肝中部周围区域。 GRK2 / 3和β-arrestin2蛋白的水平与衰老过程中激动剂激活的GPCR(包括β-ARs)的下调有关。就交感神经张力随年龄增长而论,我们的研究结果表明,尽管激动剂介导的肝β-ARs下调的增强会优先影响β2-AR亚型,但衰老过程中两种受体亚型的产生均会增加与质膜结合的β-AR的数量。 AR与肝细胞中的AC偶联。因此,这项研究确定了一种或两种β-AR亚型作为可能的治疗靶标,这些靶标涉及衰老过程中葡萄糖和脂质代谢的异常肝过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号